Related Experiment Video
Updated: Jun 5, 2025

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Comparative Study Of Oxidant Antioxidants And Inflammatory Markers Between Obese And Non Obese Newly Diagnosed COPD
Shah Mohammad Abbas Waseem1, Mohammad Mobarak Hossain2, S Aijaz Abbas Rizvi2
1Department of Physiology, IIMS & R, Integral University, Lucknow.
Abstract:
COPD has widespread systemic manifestations. Inflammation plays important role in its pathophysiology. Aim of the present study was to compare markers of oxidative stress and inflammation between obese and non obese COPD patients. The levels of pro inflammatory cytokines CRP, IL6 and TNF α were compared between obese and non-obese subjects by applying student's t test. Oxidative imbalance was assessed by analyzing MDA and FRAP assay in same subjects. Correlation of BMI with the above study parameters was analyzed using Pearson's test. Results indicated that levels of CRP, IL6 and TNF α were elevated in obese group as compared to non-obese group (p<0.001). Total antioxidant capacity estimated by FRAP assay was lower (p=0.005) but the levels of oxidants estimated indirectly by MDA was higher (p=0.01) in obese COPD patients. In all COPD patients included in present study BMI correlated inversely with FRAP (r=-0.546, p=0.013), FVC (r=0.548, p=0.012) and FEV1 (r=-0.865, p<0.001). Similarly BMI correlated positively with markers of inflammation namely CRP(r=0.526, p=0.017), IL6(r=0.865, p<0.001), TNF α (r=0.653,p=0.002). Positive correlation of BMI was found with MDA(r=0.536, p=0.015). Conclusion: there is higher inflammation in obesity resulting in oxidant antioxidant imbalance and lung function decline.
More Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: